Manufacturers developing containment systems for power morcellation procedures should test the “pull force” and “burst strength” of the finished containment units, the US Food and Drug Administration recommends in a 26 May final guidance document.
Those are just two of the dozen recommendations made in the 20-page document, which discusses the agency’s expectations for the non-clinical performance testing of the containment devices